We hypothesized that (1) adiponectin and inflammatory biomarkers would be associated with fatty liver disease independent of VAT and (2) the relationship of these markers with fatty liver disease would differ by HIV serostatus. This evidence concerns the gene ADIPOQ and fatty liver disease.